D-0065-2023 Class II Terminated

Recalled by Nephron Sterile Compounding Center LLC — West Columbia, SC

FDA drug recall D-0065-2023 was initiated by Nephron Sterile Compounding Center LLC on Nov 10, 2022 and is designated Class II. Reason for recall: CGMP Deviations: Potential for cross contamination due to product carry over. The recall status is terminated (terminated Sep 24, 2024). Affected quantity: 56,220 vials.

Recall details

Product Type
Drugs
Report Date
Nov 23, 2022
Initiation Date
Nov 10, 2022
Termination Date
Sep 24, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
56,220 vials

Product description

PF-Neostigmine Methylsulfate Injection, USP 3 mg/3 mL (1 mg/mL) vial, Rx Only, Nephron 503B Outsourcing Facility 4500 12th Street Extension West Columbia, SC 29172, NDC 69374-932-33, UPC 3 69374-93233 2.

Reason for recall

CGMP Deviations: Potential for cross contamination due to product carry over.

Distribution pattern

Nationwide in the USA

Code information

Lots: NE1062A, NE1062B Exp. 12/02/2022; NE1065A, NE1065B Exp. 12/13/2022; NE2011A, NE2011B Exp. 03/15/2022.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0065-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0065-2023. Report a data issue: hello@regdatalab.com.